{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:00:42Z","timestamp":1790949642956,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:00:00Z","timestamp":1649808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH\/NHLBI","award":["R01 HL135878"],"award-info":[{"award-number":["R01 HL135878"]}]},{"name":"NIH\/NHLBI","award":["R01 HL135878"],"award-info":[{"award-number":["R01 HL135878"]}]},{"name":"NIH\/NHLBI","award":["R01 HL135878"],"award-info":[{"award-number":["R01 HL135878"]}]},{"name":"The Lundbeck Foundation","award":["R251-2017-870"],"award-info":[{"award-number":["R251-2017-870"]}]},{"name":"Institutional Research Training Grant","award":["T32CA078207"],"award-info":[{"award-number":["T32CA078207"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA7059\/1"],"award-info":[{"award-number":["MA7059\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211100\/Z\/18\/Z"],"award-info":[{"award-number":["211100\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"The British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011722","name":"Higher Education Funding Council for England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH-NHLBI","award":["R01 HL153712-01"],"award-info":[{"award-number":["R01 HL153712-01"]}]},{"DOI":"10.13039\/100006108","name":"NIH-NCATS","doi-asserted-by":"crossref","award":["UH3TR002067"],"award-info":[{"award-number":["UH3TR002067"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20SFRN35210252"],"award-info":[{"award-number":["20SFRN35210252"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","award":["NFL-2020-218415"],"award-info":[{"award-number":["NFL-2020-218415"]}],"id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    In recent years, cardiovascular immuno-imaging by positron emission tomography (PET) has undergone tremendous progress in preclinical settings. Clinically, two approved PET tracers hold great potential for inflammation imaging in cardiovascular patients, namely FDG and DOTATATE. While the former is a widely applied metabolic tracer, DOTATATE is a relatively new PET tracer targeting the somatostatin receptor 2 (SST2). In the current study, we performed a detailed, head-to-head comparison of DOTATATE-based radiotracers and [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG in mouse and rabbit models of cardiovascular inflammation. For mouse experiments, we labeled DOTATATE with the long-lived isotope [\n                    <jats:sup>64<\/jats:sup>\n                    Cu]Cu to enable studying the tracer\u2019s mode of action by complementing in vivo PET\/CT experiments with thorough ex vivo immunological analyses. For translational PET\/MRI rabbit studies, we employed the more widely clinically used [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-labeled DOTATATE, which was approved by the FDA in 2016. DOTATATE\u2019s pharmacokinetics and timed biodistribution were determined in control and atherosclerotic mice and rabbits by ex vivo gamma counting of blood and organs. Additionally, we performed in vivo PET\/CT experiments in mice with atherosclerosis, mice subjected to myocardial infarction and control animals, using both [\n                    <jats:sup>64<\/jats:sup>\n                    Cu]Cu-DOTATATE and [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG. To evaluate differences in the tracers\u2019 cellular specificity, we performed ensuing ex vivo flow cytometry and gamma counting. In mice subjected to myocardial infarction, in vivo [\n                    <jats:sup>64<\/jats:sup>\n                    Cu]Cu-DOTATATE PET showed higher differential uptake between infarcted (SUV\n                    <jats:sub>max<\/jats:sub>\n                    1.3, IQR, 1.2\u20131.4, N\u2009=\u20094) and remote myocardium (SUV\n                    <jats:sub>max<\/jats:sub>\n                    0.7, IQR, 0.5\u20130.8, N\u2009=\u20094,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0286), and with respect to controls (SUV\n                    <jats:sub>max<\/jats:sub>\n                    0.6, IQR, 0.5\u20130.7, N\u2009=\u20094,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0286), than [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG PET. In atherosclerotic mice, [\n                    <jats:sup>64<\/jats:sup>\n                    Cu]Cu-DOTATATE PET aortic signal, but not [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG PET, was higher compared to controls (SUV\n                    <jats:sub>max<\/jats:sub>\n                    1.1, IQR, 0.9\u20131.3 and 0.5, IQR, 0.5\u20130.6, respectively, N\u2009=\u20094,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0286). In both models, [\n                    <jats:sup>64<\/jats:sup>\n                    Cu]Cu-DOTATATE demonstrated preferential accumulation in macrophages with respect to other myeloid cells, while [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG was taken up by macrophages and other leukocytes. In a translational PET\/MRI study in atherosclerotic rabbits, we then compared [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-DOTATATE and [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG for the assessment of aortic inflammation, combined with ex vivo radiometric assays and near-infrared imaging of macrophage burden. Rabbit experiments showed significantly higher aortic accumulation of both [\n                    <jats:sup>68<\/jats:sup>\n                    Ga]Ga-DOTATATE and [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG in atherosclerotic (SUV\n                    <jats:sub>max<\/jats:sub>\n                    0.415, IQR, 0.338\u20130.499, N\u2009=\u200932 and 0.446, IQR, 0.387\u20130.536, N\u2009=\u200927, respectively) compared to control animals (SUV\n                    <jats:sub>max<\/jats:sub>\n                    0.253, IQR, 0.197\u20130.285,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0002, N\u2009=\u200910 and 0.349, IQR, 0.299\u20130.423,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0159, N\u2009=\u200911, respectively). In conclusion, we present a detailed, head-to-head comparison of the novel SST2-specific tracer DOTATATE and the validated metabolic tracer [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG for the evaluation of inflammation in small animal models of cardiovascular disease. Our results support further investigations on the use of DOTATATE to assess cardiovascular inflammation as a complementary readout to the widely used [\n                    <jats:sup>18<\/jats:sup>\n                    F]F-FDG.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-09590-2","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T10:06:47Z","timestamp":1649844407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation"],"prefix":"10.1038","volume":"12","author":[{"given":"Yohana C.","family":"Toner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam A.","family":"Ghotbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonum","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy M. T.","family":"van Leent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farideh","family":"Ordikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros Marios","family":"Sofias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazz","family":"Munitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max L.","family":"Senders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Soultanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Tarkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H. F.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Giannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Ochando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"P\u00e9rez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J. M.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahi A.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"9590_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000757","author":"SS Virani","year":"2020","unstructured":"Virani, S. S. et al. Heart disease and stroke statistics\u20142020 update: A report from the American Heart Association. Circulation https:\/\/doi.org\/10.1161\/CIR.0000000000000757 (2020).","journal-title":"Circulation"},{"key":"9590_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature11260","volume":"487","author":"P Dutta","year":"2012","unstructured":"Dutta, P. et al. Myocardial infarction accelerates atherosclerosis. Nature 487, 325\u2013329 (2012).","journal-title":"Nature"},{"key":"9590_CR3","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurheartj\/ehy124","volume":"39","author":"L Tomas","year":"2018","unstructured":"Tomas, L. et al. Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques. Eur. Heart J. 39, 2301\u20132310 (2018).","journal-title":"Eur. Heart J."},{"key":"9590_CR4","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"DM Fernandez","year":"2019","unstructured":"Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576\u20131588 (2019).","journal-title":"Nat. Med."},{"key":"9590_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"9590_CR6","unstructured":"Tardif, J. et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. To cite this version\u202f: HAL Id\u202f: hal-02368804. (2020)."},{"key":"9590_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12410-017-9399-z","volume":"10","author":"M Kircher","year":"2017","unstructured":"Kircher, M. & Lapa, C. Novel noninvasive nuclear medicine imaging techniques for cardiac inflammation. Curr. Cardiovasc. Imaging Rep. 10, 1\u201313 (2017).","journal-title":"Curr. Cardiovasc. Imaging Rep."},{"key":"9590_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-020-01372-4","volume":"22","author":"A \u0106orovi\u0107","year":"2020","unstructured":"\u0106orovi\u0107, A., Wall, C., Mason, J. C., Rudd, J. H. F. & Tarkin, J. M. Novel positron emission tomography tracers for imaging vascular inflammation. Curr. Cardiol. Rep. 22, 1\u201311 (2020).","journal-title":"Curr. Cardiol. Rep."},{"key":"9590_CR9","first-page":"455","volume":"45","author":"S Maschauer","year":"2004","unstructured":"Maschauer, S., Prante, O., Hoffmann, M., Deichen, J. T. & Kuwert, T. Characterization of 18F-FDG uptake in human endothelial cells in vitro. J. Nucl. Med. 45, 455\u2013460 (2004).","journal-title":"J. Nucl. Med."},{"key":"9590_CR10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.jacc.2019.06.057","volume":"74","author":"RH Al-Mashhadi","year":"2019","unstructured":"Al-Mashhadi, R. H. et al. 18Fluorodeoxyglucose accumulation in arterial tissues determined by PET signal analysis. J. Am. Coll. Cardiol. 74, 1220\u20131232 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9590_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5603\/NMR.2012.0010","volume":"15","author":"M Kobylecka","year":"2012","unstructured":"Kobylecka, M. et al. Myocardial viability assessment in 18FDG PET\/CT study (18FDG PET myocardial viability assessment). Nucl. Med. Rev. 15, 52\u201360 (2012).","journal-title":"Nucl. Med. Rev."},{"key":"9590_CR12","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s12350-017-1131-5","volume":"25","author":"O Manabe","year":"2018","unstructured":"Manabe, O. et al. Radiopharmaceutical tracers for cardiac imaging. J. Nucl. Cardiol. 25, 1204\u20131236 (2018).","journal-title":"J. Nucl. Cardiol."},{"key":"9590_CR13","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.2967\/jnumed.107.041574","volume":"48","author":"E Inglese","year":"2007","unstructured":"Inglese, E. et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET\/CT. J. Nucl. Med. 48, 1662\u20131669 (2007).","journal-title":"J. Nucl. Med."},{"key":"9590_CR14","first-page":"1749","volume":"31","author":"RJ Gropler","year":"1990","unstructured":"Gropler, R. J. et al. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J. Nucl. Med. 31, 1749\u20131756 (1990).","journal-title":"J. Nucl. Med."},{"key":"9590_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-020-02046-y","author":"EJ Meester","year":"2020","unstructured":"Meester, E. J. et al. Imaging inflammation in atherosclerotic plaques, targeting SST2 with [111In]In-DOTA-JR11. J. Nucl. Cardiol. https:\/\/doi.org\/10.1007\/s12350-020-02046-y (2020).","journal-title":"J. Nucl. Cardiol."},{"key":"9590_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41565-020-0642-4","volume":"15","author":"ML Senders","year":"2020","unstructured":"Senders, M. L. et al. Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging. Nat. Nanotechnol. 15, 398\u2013405 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"9590_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.23736\/S1824-4785.20.03230-6","volume":"64","author":"GS Heo","year":"2020","unstructured":"Heo, G. S., Sultan, D. & Liu, Y. Current and novel radiopharmaceuticals for imaging cardiovascular inflammation. Q. J. Nucl. Med. Mol. Imaging 64, 4\u201320 (2020).","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"9590_CR18","unstructured":"Gipharma S.r.l. NETSPOT (kit for the preparation of gallium Ga 68 dotatate injection). 1\u201313 (2016)."},{"key":"9590_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2967\/jnumed.116.180430","volume":"58","author":"CB Johnbeck","year":"2017","unstructured":"Johnbeck, C. B. et al. Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET\/CT: A prospective study of 59 patients with neuroendocrine tumors. J. Nucl. Med. 58, 451\u2013457 (2017).","journal-title":"J. Nucl. Med."},{"key":"9590_CR20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","volume":"69","author":"JM Tarkin","year":"2017","unstructured":"Tarkin, J. M. et al. Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging. J. Am. Coll. Cardiol. 69, 1774\u20131791 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9590_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2013.06.018","volume":"230","author":"X Li","year":"2013","unstructured":"Li, X. et al. Specific somatostatin receptor II expression in arterial plaque: 68Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis 230, 33\u201339 (2013).","journal-title":"Atherosclerosis"},{"key":"9590_CR22","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2967\/jnumed.115.161216","volume":"56","author":"C Malmberg","year":"2015","unstructured":"Malmberg, C. et al. 64Cu-DOTATATE for noninvasive assessment of atherosclerosis in large arteries and its correlation with risk factors: Head-to-head comparison with 68Ga-DOTATOC in 60 patients. J. Nucl. Med. 56, 1895\u20131900 (2015).","journal-title":"J. Nucl. Med."},{"key":"9590_CR23","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","volume":"73","author":"JM Tarkin","year":"2019","unstructured":"Tarkin, J. M. et al. 68Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction. J. Am. Coll. Cardiol. 73, 2489\u20132491 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9590_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00259-014-2884-6","volume":"42","author":"JT Thackeray","year":"2015","unstructured":"Thackeray, J. T. et al. Targeting post-infarct inflammation by PET imaging: Comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model. Eur. J. Nucl. Med. Mol. Imaging 42, 317\u2013327 (2015).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"9590_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.066","author":"WW Lee","year":"2012","unstructured":"Lee, W. W. et al. PET\/MRI of inflammation in myocardial infarction. J. Am. Coll. Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.066 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"9590_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jcmg.2018.05.026","volume":"11","author":"JT Thackeray","year":"2018","unstructured":"Thackeray, J. T. & Bengel, F. M. Molecular imaging of myocardial inflammation with positron emission tomography post-ischemia: A determinant of subsequent remodeling or recovery. JACC Cardiovasc. Imaging 11, 1340\u20131355 (2018).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"9590_CR27","doi-asserted-by":"publisher","first-page":"eaaw7736","DOI":"10.1126\/scitranslmed.aaw7736","volume":"11","author":"T Binderup","year":"2019","unstructured":"Binderup, T. et al. Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species. Sci. Transl. Med. 11, eaaw7736 (2019).","journal-title":"Sci. Transl. Med."},{"key":"9590_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nuclcard.2005.03.002","volume":"12","author":"A Tawakol","year":"2005","unstructured":"Tawakol, A. et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J. Nucl. Cardiol. 12, 294\u2013301 (2005).","journal-title":"J. Nucl. Cardiol."},{"key":"9590_CR29","first-page":"1","volume":"8","author":"QM Zhao","year":"2013","unstructured":"Zhao, Q. M. et al. Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET\/CT. PLoS ONE 8, 1\u20139 (2013).","journal-title":"PLoS ONE"},{"key":"9590_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2014.00070","volume":"5","author":"G Pelosi","year":"2014","unstructured":"Pelosi, G. et al. Inflammation blood and tissue factors of plaque growth in an experimental model evidenced by a systems approach. Front. Genet. 5, 1\u20136 (2014).","journal-title":"Front. Genet."},{"key":"9590_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2014.80","volume":"11","author":"JM Tarkin","year":"2014","unstructured":"Tarkin, J. M., Joshi, F. R. & Rudd, J. H. F. PET imaging of inflammation in atherosclerosis. Nat. Rev. Cardiol. 11, 443\u2013457 (2014).","journal-title":"Nat. Rev. Cardiol."},{"key":"9590_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-2-52","volume":"2","author":"X Li","year":"2012","unstructured":"Li, X. et al. 68Ga-DOTATATE PET\/CT for the detection of inflammation of large arteries: Correlation with 18F-FDG, calcium burden and risk factors. EJNMMI Res. 2, 1\u201310 (2012).","journal-title":"EJNMMI Res."},{"key":"9590_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2967\/jnumed.109.070672","volume":"51","author":"A Rominger","year":"2010","unstructured":"Rominger, A. et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET\/CT: Correlation with coronary calcium burden and risk factors. J. Nucl. Med. 51, 193\u2013197 (2010).","journal-title":"J. Nucl. Med."},{"key":"9590_CR34","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1161\/ATVBAHA.114.305067","volume":"35","author":"SF Pedersen","year":"2015","unstructured":"Pedersen, S. F. et al. 64Cu-DOTATATE PET\/MRI for detection of activated macrophages in carotid atherosclerotic plaques: Studies in patients undergoing endarterectomy. Arterioscler. Thromb. Vasc. Biol. 35, 1696\u20131703 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"9590_CR35","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2967\/jnumed.116.181438","volume":"58","author":"MYS Wan","year":"2017","unstructured":"Wan, M. Y. S. et al. PET\/CT imaging of unstable carotid plaque with 68Ga-labeled somatostatin receptor ligand. J. Nucl. Med. 58, 774\u2013780 (2017).","journal-title":"J. Nucl. Med."},{"key":"9590_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/RLU.0000000000001894","volume":"43","author":"\u00c9 Vall\u00e9e","year":"2018","unstructured":"Vall\u00e9e, \u00c9., Paquet, N., Buteau, J. P. & Turcotte, \u00c9. 68Ga-DOTATATE uptake in ischemic stroke. Clin. Nucl. Med. 43, 46\u201347 (2018).","journal-title":"Clin. Nucl. Med."},{"key":"9590_CR37","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.2967\/jnumed.113.120600","volume":"54","author":"M Sandstr\u00f6m","year":"2013","unstructured":"Sandstr\u00f6m, M. et al. Comparative biodistribution and radiation dosimetry of 68Ga- DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors. J. Nucl. Med. 54, 1755\u20131759 (2013).","journal-title":"J. Nucl. Med."},{"key":"9590_CR38","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2967\/jnumed.111.101469","volume":"53","author":"A Pfeifer","year":"2012","unstructured":"Pfeifer, A. et al. Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: First-in-humans study. J. Nucl. Med. 53, 1207\u20131215 (2012).","journal-title":"J. Nucl. Med."},{"key":"9590_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2967\/jnumed.119.233015","volume":"61","author":"TL Andersen","year":"2020","unstructured":"Andersen, T. L., Baun, C., Olsen, B. B., Dam, J. H. & Thisgaard, H. Improving contrast and detectability: Imaging with [55Co]Co-DOTATATE in comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE. J. Nucl. Med. 61, 228\u2013235 (2020).","journal-title":"J. Nucl. Med."},{"key":"9590_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2008.12.011","volume":"36","author":"RS Liu","year":"2009","unstructured":"Liu, R. S. et al. Biodistribution, pharmacokinetics and PET Imaging of [18F]FMISO, [18F]FDG and [18F]FAc in a sarcoma- and inflammation-bearing mouse model. Nucl. Med. Biol. 36, 305\u2013312 (2009).","journal-title":"Nucl. Med. Biol."},{"key":"9590_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11307-015-0873-1","volume":"18","author":"P Rinne","year":"2016","unstructured":"Rinne, P. et al. Comparison of somatostatin receptor 2-targeting PET tracers in the detection of mouse atherosclerotic plaques. Mol. Imaging Biol. 18, 99\u2013108 (2016).","journal-title":"Mol. Imaging Biol."},{"key":"9590_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0165-5728(03)00094-8","volume":"138","author":"J Perez","year":"2003","unstructured":"Perez, J. et al. Somatostatin binds to murine macrophages through two distinct subsets of receptors. J. Neuroimmunol. 138, 38\u201344 (2003).","journal-title":"J. Neuroimmunol."},{"key":"9590_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1152\/ajpendo.00048.2003","volume":"285","author":"VASH Dalm","year":"2003","unstructured":"Dalm, V. A. S. H. et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am. J. Physiol. Endocrinol. Metab. 285, 344\u2013353 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"9590_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cmmi.232","volume":"3","author":"M Fani","year":"2008","unstructured":"Fani, M., Andr\u00e9, J. P. & Maecke, H. R. 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol. Imaging 3, 53\u201363 (2008).","journal-title":"Contrast Media Mol. Imaging"},{"key":"9590_CR45","first-page":"65","volume":"5","author":"A Mojtahedi","year":"2015","unstructured":"Mojtahedi, A. et al. Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET\/CT. Am. J. Nucl. Med. Mol. Imaging 5, 65\u201371 (2015).","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"9590_CR46","doi-asserted-by":"publisher","first-page":"e50908","DOI":"10.1371\/journal.pone.0050908","volume":"7","author":"AMF Hag","year":"2012","unstructured":"Hag, A. M. F. et al. 18F-FDG PET imaging of murine atherosclerosis: Association with gene expression of key molecular markers. PLoS ONE 7, e50908 (2012).","journal-title":"PLoS ONE"},{"key":"9590_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2017.04.004","volume":"263","author":"S Hellberg","year":"2017","unstructured":"Hellberg, S. et al. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr\u2212\/\u2212Apob100\/100 mice. Atherosclerosis 263, 369\u2013376 (2017).","journal-title":"Atherosclerosis"},{"key":"9590_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0099441","volume":"9","author":"J Toczek","year":"2014","unstructured":"Toczek, J. et al. Periaortic brown adipose tissue as a major determinant of [18F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, ApoE\u2212\/\u2212 mice. PLoS ONE 9, 1\u20139 (2014).","journal-title":"PLoS ONE"},{"key":"9590_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-019-01929-z","author":"T Borchert","year":"2019","unstructured":"Borchert, T. et al. Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals. J. Nucl. Cardiol. https:\/\/doi.org\/10.1007\/s12350-019-01929-z (2019).","journal-title":"J. Nucl. Cardiol."},{"key":"9590_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1152\/physiolgenomics.00041.2003","volume":"16","author":"O Tarnavski","year":"2004","unstructured":"Tarnavski, O. et al. Mouse cardiac surgery: Comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol. Genomics 16, 349\u2013360 (2004).","journal-title":"Physiol. Genomics"},{"key":"9590_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1186\/s12938-016-0270-2","volume":"15","author":"R Xing","year":"2016","unstructured":"Xing, R. et al. Contrast-enhanced micro-CT imaging in murine carotid arteries: A new protocol for computing wall shear stress. Biomed. Eng. Online 15, 621\u2013636 (2016).","journal-title":"Biomed. Eng. Online"},{"key":"9590_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/00006231-200107000-00004","volume":"22","author":"RJ Lederman","year":"2001","unstructured":"Lederman, R. J. et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl. Med. Commun. 22, 747\u2013753 (2001).","journal-title":"Nucl. Med. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09590-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:39:42Z","timestamp":1669322382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09590-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09590-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1083300\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,13]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andreas Kjaer is an inventor on a patent\/holds IPR regarding the use of [<sup>64<\/sup>Cu]Cu-DOTATATE in neuroendocrine tumor patients. The other authors report no Relationship with Industry and Other Entities. No other potential conflicts of interest relevant to this article exist.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6185"}}